Position in LLY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$780,151,673
-$120,061,635 QoQ
Shares Held
848,203
+1.3% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
1.52%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $2,592,331,857 across 12 Drug Manufacturers - General names. LLY ranks #1 (30.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
848,203 | $780,151,673 | |
| 2 | JNJ |
Johnson & Johnson
|
1,965,769 | $480,512,574 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
2,338,222 | $325,878,000 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,613,009 | $314,318,852 | |
| 5 | ABBV |
AbbVie Inc.
|
1,226,870 | $266,831,956 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,001,221 | $182,024,053 | |
| 7 | PFE |
Pfizer Inc
|
4,829,237 | $135,604,974 | |
| 8 | AMGN |
Amgen Inc
|
214,379 | $75,429,251 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $780,151,673 | 848,203 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $900,213,308 | 837,657 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $478,414,734 | 627,018 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $678,132,635 | 869,925 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $739,932,769 | 895,900 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $678,694,536 | 879,138 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $776,448,447 | 876,412 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $807,522,002 | 891,915 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $721,366,521 | 927,254 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $411,498,966 | 705,927 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $315,950,071 | 588,219 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $411,007,037 | 876,385 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $243,470,699 | 708,959 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $153,035,993 | 418,314 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $125,494,398 | 388,107 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $90,299,676 | 278,505 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $143,303,843 | 500,415 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $177,939,819 | 644,196 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $156,591,595 | 677,739 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $230,698,585 | 1,005,135 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $196,158,384 | 1,049,986 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $130,241,825 | 771,392 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $125,362,134 | 846,927 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $133,815,894 | 815,056 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $36,799,780 | 265,281 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||